Perry Spratt
Program Director | Neuroscientist
- Role
- Program Director, in Vivo Preclinical Programs at Regel Therapeutics
- Location
- Seattle, WA, US
- LinkedIn followers
- 500 followers
About Perry Spratt
Neuroscientist turned Program Director with 15 years of research experience spanning academic and industry settings. I lead in vivo preclinical programs at Regel Therapeutics, applying our EpiEditing technology to tackle difficult-to-treat epilepsy and neurodevelopmental disorders—advancing pipeline assets from in vitro target validation through IND-enabling studies.I\'m passionate about translating cutting-edge science into therapies, building partnerships across academia, industry, and patient communities, and exploring how emerging tools like AI can accelerate scientific discovery.
Experience
Program Director, in Vivo Preclinical Programs
Jan 2024 — Present · Seattle, WA, US
I lead Regel\'s in vivo preclinical programs, managing a cross-functional team of 8 and coordinating partnerships with 6 CRO partners to advance gene therapies from proof-of-concept through IND-enabling studies across CNS, cardiac, and skeletal muscle indications- Scaled the in vivo team from 2 to 8 FTEs to support expansion into new therapeutic areas- Co-authored FDA INTERACT submission for lead CNS programAnnual Meeting- Presented preclinical results at Gene Therapy for CNS Summit and American Epilepsy Society
Education
University of California, San Francisco
Doctor of Philosophy (Ph.D.), Neuroscience
2014 — 2020
McGill University
Bachelor’s Degree, Honours Neuroscience
2010 — 2014
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.